首页 正文

Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour

{{output}}
Background: Infantile inflammatory myofibroblastic tumour (IMT) is rare and the majority are driven by anaplastic lymphoma kinase (ALK) rearrangements. Previous literature on the use of ALK inhibitors in paediatric IMTs is extrem... ...